Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00818220 · ClinicalTrials.gov registry record · Phase 2

Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants

A Phase 2 study, sponsored by University of Rhode Island.

Completed
Registry status
Phase 2
Development phase
211
Enrollment target

NCT00818220: Completed Phase 2 study, sponsored by University of Rhode Island.

NCT00818220 is a Phase 2 study that has completed, run by University of Rhode Island. The registered enrollment target is 211 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00818220, a Phase 2 study, has completed, sponsored by University of Rhode Island.

COMPLETED
Registry status
Phase 2
Development phase
211 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the intervention of delaying cord clamping for 30 to 45 seconds followed by one milking of the cord while simultaneously lowering the VLBW infants below the introitus will result in less bleeding in the brain and fewer infections while in the Neonatal Intensive Care Unit (NICU) and better motor skills at 7 months corrected age. The investigators will attempt to identify the mechanisms of effect through measurement of biologic markers.

Interventions

  • PROCEDURE delayed umbilical cord clamping
  • OTHER Immediate cord clamping

Trial Details

FieldValue
Enrollment Target 211 participants
Start Date 2008-02
Est. Completion 2014-03
Phase Phase 2
University of Rhode Island

29 total trials

What the finished NCT00818220 record still lists

NCT00818220 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% higher).

The record links to 0 conditions, and to 2 interventions - of which delayed umbilical cord clamping is the first listed.

NCT00818220 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00818220 about?

NCT00818220 is a clinical study titled "Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants". The purpose of this study is to determine whether the intervention of delaying cord clamping for 30 to 45 seconds followed by one milking of the cord while simultaneously lowering the VLBW infants below the introitus will result in less bleeding in the brain and fewer infections while in the Neonata...

What is the current status of trial NCT00818220?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 211 participants. The study started on 2008-02. Estimated completion is 2014-03.

What interventions are being tested in trial NCT00818220?

The interventions under investigation include: delayed umbilical cord clamping (PROCEDURE), Immediate cord clamping (OTHER).

Who is sponsoring clinical trial NCT00818220?

This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00818220's enrollment target sits among peer trials

211 290th of 2000 higher than 1,711 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06698796 · 211 participants · Phase 3

    A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00818220, the US trial registry maintained by the National Library of Medicine. NCT00818220 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.